TSS Strong Revenue and Margin Expansion
Thermal & Specialized Solutions (TSS) delivered a record first quarter: net sales +22% year-over-year and +28% sequentially, driven by higher pricing, stronger volumes and favorable mix. TSS achieved record adjusted EBITDA with margins expanding to 33%. Company-wide pricing was up ~3% sequentially.
Titanium Technologies (TT) Outperformance
TT exceeded earnings expectations in the quarter, with adjusted EBITDA beating forecasts due to disciplined global pricing actions and cost management. The business signed a long-term chlorine supply contract to secure feedstock for DeLisle starting in 2028, supporting low-cost chloride TiO2 production.
Strong Q2 and Consolidated Guidance
Management expects Q2 sequential consolidated net sales growth of 15%–20% and consolidated adjusted EBITDA of $220M–$250M. Segment guidance includes TSS/PFS adjusted EBITDA of $210M–$225M and TT adjusted EBITDA of $40M–$50M; APM net sales expected to rise low–high 30% sequentially.
APM Order Book Strength in High-Value End Markets
Advanced Performance Materials (APM) reported strong order velocity, particularly in semiconductor and data center markets. Management expects APM adjusted EBITDA to improve to $12M–$18M in Q2 and aims for segment EBITDA in the $30M–$40M range in the back half of 2026 as operations normalize.
Balance Sheet and Liquidity Improvements
Completed sale of nearly all Kuan Yin properties ahead of schedule (remaining parcel expected to yield ~$60M gross proceeds) and used proceeds to pay down near-term debt. Reduced debt by approximately $160M and completed a $700M refinancing in March that extends maturities to 2034. Free cash flow for Q2 expected to be at least $100M; capex guided ~$50M.
Operational and Commercial Execution
Company implemented the Chemours Business System (CBS) with early positive outcomes, continued disciplined quota allocation and successful pricing actions (December and April). Management emphasized operational reliability improvements and continued focus on cost control and supply security.
Full-Year Outlook and Leverage Path
Full-year net sales, adjusted EBITDA and capex are expected to align with prior guidance. Net leverage is expected to be below 3.8x adjusted EBITDA by year-end 2026 with a pathway toward target leverage below 3x, and anticipated annual interest expense savings of approximately $9M by year-end after debt repayments.